SJ Medical
SJ Medical
The global cardiovascular intervention market is witnessing an unprecedented surge, primarily driven by an aging population and the increasing prevalence of coronary artery disease (CAD). Sirolimus Eluting Stents (SES) have emerged as the gold standard in Percutaneous Coronary Intervention (PCI). Unlike bare-metal stents, SES utilize a specialized drug coating—Sirolimus (also known as Rapamycin)—to inhibit neointimal hyperplasia, significantly reducing the rates of in-stent restenosis (ISR).
As a leading China Sirolimus Eluting Stent Factory, we understand that the industry has moved beyond simple scaffolding. Today’s market demands "Smart Stents" that offer biocompatibility, thin-strut profiles for better deliverability, and controlled drug release kinetics. China has positioned itself at the epicenter of this industrial shift, combining high-tech manufacturing with rigorous clinical validation to serve healthcare providers from Europe to Southeast Asia.
The global drug-eluting stent market is projected to grow at a CAGR of 5.8% through 2030, with China being the largest manufacturer of high-quality, cost-effective interventional components.
A significant trend is the transition toward polymer-free or bioresorbable polymer coatings to minimize long-term inflammatory responses and improve late lumen gain.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
GMP Compliance in Critical Processes
Cost Efficiency vs Western Competitors
Global Regions Served with ISO 13485
Continuous Clinical Innovation Pipeline
Procurement managers from multi-national hospitals and medical distribution groups prioritize three factors: Clinical Reliability, Regulatory Compliance, and Supply Chain Resilience. China's top Sirolimus Eluting Stent factories, like SJ Medical, offer a unique value proposition. By integrating advanced laser-cutting technologies from Germany with localized large-scale production, we provide stents that match the clinical performance of "Big Pharma" brands at a fraction of the cost. This allows healthcare systems in emerging markets to expand patient access to life-saving PCI procedures.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
In emergency settings, the deliverability of the Sirolimus Eluting Stent is paramount. Our low-profile balloon-expandable systems allow for rapid cross-lesion delivery even in tortuous vessels.
For complex cases, our specialized stents provide the necessary radial force to keep calcified vessels patent while the Sirolimus coating prevents long-term scarring.
Beyond the heart, SJ Medical’s expertise extends to peripheral stents for the iliac and femoral arteries, addressing the growing global need for limb salvage procedures.
Our diversification into urology, including disposable pigtail catheters, demonstrates our holistic approach to stent-based therapeutic solutions.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
The company is equipped with advanced production and inspection systems, including:
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence.
Our commitment to "Our Services" (h2 id="175md9f") ensures that every global partner receives comprehensive pre-sales consultation, technical support, and responsive after-sales service.
